TYP-III-CRISPR/CAS-BASIERTE DIAGNOSTIK

Patent europeic · EP4497833 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4497833
Numer da la dumonda
EP24207925
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-06-2020
Publitgà
29-01-2025
Concedì
26-08-2026
La protecziun finescha il pli tard
18-06-2040
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C12Q 1/6816 (2018.01)
Prioritad
EP 19181371 19.06.2019
EP 20168487 07.04.2020
Derivà da
EP20744159
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 07-09-2026

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 07.09.2026

  2. 26-08-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.08.2026

Partidas

Possessur

SCOPE BIOSCIENCES B.V.

Bronland 12B-1, 6708 WH Wageningen, NL

Represchentant

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventur

STEENS, Aiko Jurre

6721 BK Bennekom, NL

PRINSEN, Stijn Hendrikus Petrus

6708 PG Wageningen, NL

VAN DER OOST, John

6871 HZ Renkum, NL

STAALS, Raymond Hubert Josèphe

6711NZ Ede, NL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.